Literature DB >> 20532838

Management of cryptococcal meningitis in sub-saharan Africa.

Arthur Jackson1, Mina C Hosseinipour.   

Abstract

Cryptococcal meningitis (CM) is a common form of meningitis in sub-Saharan Africa due to the high prevalence of HIV/AIDS. This report outlines the management of CM with a focus on resource-limited settings. Sections covered include epidemiology and diagnosis, pharmacotherapy, management of complications, timing of antiretrovirals, and primary and secondary prevention of CM. Emphasis has been given to recent articles and landmark trials, and opinion is given from the authors' own experiences.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20532838     DOI： 10.1007/s11904-010-0052-6

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN： 1548-3568            Impact factor:   5.071


  46 in total

1.  Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.

Authors:  Annemarie E Brouwer; Adul Rajanuwong; Wirongrong Chierakul; George E Griffin; Robert A Larsen; Nicholas J White; Thomas S Harrison
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

2.  Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.

Authors:  Azure T Makadzange; Chiratidzo E Ndhlovu; Kudakwashe Takarinda; Michael Reid; Magna Kurangwa; Philimon Gona; James G Hakim
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

3.  A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors:  M S Saag; G A Cloud; J R Graybill; J D Sobel; C U Tuazon; P C Johnson; W J Fessel; B L Moskovitz; B Wiesinger; D Cosmatos; L Riser; C Thomas; R Hafner; W E Dismukes
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

4.  Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.

Authors:  D Maher; H Mwandumba
Journal:  J Infect       Date:  1994-01       Impact factor: 6.072

5.  Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.

Authors:  Eric Milefchik; Mary Ann Leal; Richard Haubrich; Samuel A Bozzette; Jeremiah G Tilles; John M Leedom; J Allen McCutchan; Robert A Larsen
Journal:  Med Mycol       Date:  2008-06       Impact factor: 4.076

6.  High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.

Authors:  Tihana Bicanic; Robin Wood; Graeme Meintjes; Kevin Rebe; Annemarie Brouwer; Angela Loyse; Linda-Gail Bekker; Shabbar Jaffar; Thomas Harrison
Journal:  Clin Infect Dis       Date:  2008-07-01       Impact factor: 9.079

7.  A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.

Authors:  S A Bozzette; R A Larsen; J Chiu; M A Leal; J Jacobsen; P Rothman; P Robinson; G Gilbert; J A McCutchan; J Tilles
Journal:  N Engl J Med       Date:  1991-02-28       Impact factor: 91.245

8.  Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.

Authors:  Tihana Bicanic; Conrad Muzoora; Annemarie E Brouwer; Graeme Meintjes; Nicky Longley; Kabanda Taseera; Kevin Rebe; Angela Loyse; Joseph Jarvis; Linda-Gail Bekker; Robin Wood; Direk Limmathurotsakul; Wirongrong Chierakul; Kasia Stepniewska; Nicholas J White; Shabbar Jaffar; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

9.  Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.

Authors:  Andrew Zolopa; Janet Andersen; William Powderly; Alejandro Sanchez; Ian Sanne; Carol Suckow; Evelyn Hogg; Lauren Komarow
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

10.  Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

Authors:  Françoise Dromer; Simone Mathoulin-Pélissier; Odile Launay; Olivier Lortholary
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069
View more
  9 in total

1.  When smear and molecular diagnostics fail: identification of tuberculosis in advanced HIV infection using the newly developed urine lipoarabinomannan lateral-flow assay.

Authors:  Ashar Vijay Dhana; Pauline Howell; David Spencer
Journal:  BMJ Case Rep       Date:  2014-03-10

2.  Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex.

Authors:  Nívea Pereira de Sá; Caroline Miranda de Lima; Cleudiomar Inácio Lino; Paulo Jorge Sanches Barbeira; Ludmila de Matos Baltazar; Daniel Assis Santos; Renata Barbosa de Oliveira; Eleftherios Mylonakis; Beth Burgwyn Fuchs; Susana Johann
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis.

Authors:  Emily W Bratton; Nada El Husseini; Cody A Chastain; Michael S Lee; Charles Poole; Til Stürmer; David J Weber; Jonathan J Juliano; John R Perfect
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

4.  Clinical characteristics, Cryptococcus neoformans genotypes, antifungal susceptibility, and outcomes in human immunodeficiency virus-positive patients in Beijing, China.

Authors:  Xinmin Xu; Pengcheng Du; Huizhu Wang; Xiaoling Yang; Tingting Liu; Yuanyuan Zhang; Yajie Wang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

5.  Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus.

Authors:  Sruti S Velamakanni; Nathan C Bahr; Abdu K Musubire; David R Boulware; Joshua Rhein; Henry W Nabeta
Journal:  Med Mycol Case Rep       Date:  2014-08-11

Review 6.  Neurological disorders in HIV in Africa: a review.

Authors:  William P Howlett
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

7.  High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand.

Authors:  Julie R Harris; Mark D Lindsley; Sununta Henchaichon; Natteewan Poonwan; Sathapana Naorat; Prabda Prapasiri; Somrak Chantra; Fuangrak Ruamcharoen; Loretta S Chang; Malinee Chittaganpitch; Nanthawan Mehta; Leonard Peruski; Susan A Maloney; Benjamin J Park; Henry C Baggett
Journal:  Clin Infect Dis       Date:  2011-12-23       Impact factor: 9.079

8.  Magnitude of Cryptococcosis among HIV patients in sub-Saharan Africa countries: a systematic review and meta-analysis.

Authors:  Tsegaye Alemayehu; Sosina Ayalew; Temesgen Buzayehu; Deresse Daka
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

9.  HECT E3 Ubiquitin Ligase Nedd4 Is Required for Antifungal Innate Immunity.

Authors:  Patrick K Nuro-Gyina; Na Tang; Hui Guo; Chengkai Yan; Qiuming Zeng; Thomas J Waldschmidt; Jian Zhang
Journal:  J Immunol       Date:  2021-07-19       Impact factor: 5.426
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.